Depression-like symptoms of withdrawal in a genetic mouse model of binge methamphetamine intake

Shkelzen Shabani, Bryan Schmidt, Bikalpa Ghimire, Sydney K. Houlton, Laura Hellmuth, Erika Mojica, Tamara Phillips

Research output: Contribution to journalArticle

Abstract

Binge methamphetamine (MA) users have higher MA consumption, relapse rates and depression-like symptoms during early periods of withdrawal, compared with non-binge users. The impact of varying durations of MA abstinence on depression-like symptoms and on subsequent MA intake was examined in mice genetically prone to binge-level MA consumption. Binge-level MA intake was induced using a multiple-bottle choice procedure in which mice were offered one water drinking tube and three tubes containing increasing concentrations of MA in water, or four water tubes (control group). In two studies, depression-like symptoms were measured using a tail-suspension test and a subsequent forced-swim test, after forced abstinence of 6 and 30 hours from a 28-day course of chronic MA intake. An additional study measured the same depression-like symptoms, as well as MA intake, after prolonged abstinence of 1 and 2 weeks. MA high drinking mice and one of their progenitor strains DBA/2J escalated their MA intake with increasing MA concentration; however, MA high drinking mice consumed almost twice as much MA as DBA/2J mice. Depression-like symptoms were significantly higher early after MA access was withdrawn, compared to levels in drug-naïve controls, with more robust effects of MA withdrawal observed in MA high drinking than DBA/2J mice. When depression-like symptoms were examined after 1 or 2 weeks of forced abstinence in MA high drinking mice, depression-like symptoms dissipated, and subsequent MA intake was high. The MA high drinking genetic mouse model has strong face validity for human binge MA use and behavioral sequelae associated with abstinence.

Original languageEnglish (US)
Article numbere12533
JournalGenes, Brain and Behavior
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Substance Withdrawal Syndrome
Methamphetamine
Genetic Models
Depression
Drinking
Inbred DBA Mouse
Hindlimb Suspension

Keywords

  • 4-bottle choice
  • addiction
  • forced abstinence
  • forced-swim test
  • selected-lines
  • tail-suspension test

ASJC Scopus subject areas

  • Genetics
  • Neurology
  • Behavioral Neuroscience

Cite this

Shabani, S., Schmidt, B., Ghimire, B., Houlton, S. K., Hellmuth, L., Mojica, E., & Phillips, T. (Accepted/In press). Depression-like symptoms of withdrawal in a genetic mouse model of binge methamphetamine intake. Genes, Brain and Behavior, [e12533]. https://doi.org/10.1111/gbb.12533

Depression-like symptoms of withdrawal in a genetic mouse model of binge methamphetamine intake. / Shabani, Shkelzen; Schmidt, Bryan; Ghimire, Bikalpa; Houlton, Sydney K.; Hellmuth, Laura; Mojica, Erika; Phillips, Tamara.

In: Genes, Brain and Behavior, 01.01.2018.

Research output: Contribution to journalArticle

Shabani, Shkelzen ; Schmidt, Bryan ; Ghimire, Bikalpa ; Houlton, Sydney K. ; Hellmuth, Laura ; Mojica, Erika ; Phillips, Tamara. / Depression-like symptoms of withdrawal in a genetic mouse model of binge methamphetamine intake. In: Genes, Brain and Behavior. 2018.
@article{e6015bbb53c3483baf571227af7bc405,
title = "Depression-like symptoms of withdrawal in a genetic mouse model of binge methamphetamine intake",
abstract = "Binge methamphetamine (MA) users have higher MA consumption, relapse rates and depression-like symptoms during early periods of withdrawal, compared with non-binge users. The impact of varying durations of MA abstinence on depression-like symptoms and on subsequent MA intake was examined in mice genetically prone to binge-level MA consumption. Binge-level MA intake was induced using a multiple-bottle choice procedure in which mice were offered one water drinking tube and three tubes containing increasing concentrations of MA in water, or four water tubes (control group). In two studies, depression-like symptoms were measured using a tail-suspension test and a subsequent forced-swim test, after forced abstinence of 6 and 30 hours from a 28-day course of chronic MA intake. An additional study measured the same depression-like symptoms, as well as MA intake, after prolonged abstinence of 1 and 2 weeks. MA high drinking mice and one of their progenitor strains DBA/2J escalated their MA intake with increasing MA concentration; however, MA high drinking mice consumed almost twice as much MA as DBA/2J mice. Depression-like symptoms were significantly higher early after MA access was withdrawn, compared to levels in drug-na{\"i}ve controls, with more robust effects of MA withdrawal observed in MA high drinking than DBA/2J mice. When depression-like symptoms were examined after 1 or 2 weeks of forced abstinence in MA high drinking mice, depression-like symptoms dissipated, and subsequent MA intake was high. The MA high drinking genetic mouse model has strong face validity for human binge MA use and behavioral sequelae associated with abstinence.",
keywords = "4-bottle choice, addiction, forced abstinence, forced-swim test, selected-lines, tail-suspension test",
author = "Shkelzen Shabani and Bryan Schmidt and Bikalpa Ghimire and Houlton, {Sydney K.} and Laura Hellmuth and Erika Mojica and Tamara Phillips",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/gbb.12533",
language = "English (US)",
journal = "Genes, Brain and Behavior",
issn = "1601-1848",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Depression-like symptoms of withdrawal in a genetic mouse model of binge methamphetamine intake

AU - Shabani, Shkelzen

AU - Schmidt, Bryan

AU - Ghimire, Bikalpa

AU - Houlton, Sydney K.

AU - Hellmuth, Laura

AU - Mojica, Erika

AU - Phillips, Tamara

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Binge methamphetamine (MA) users have higher MA consumption, relapse rates and depression-like symptoms during early periods of withdrawal, compared with non-binge users. The impact of varying durations of MA abstinence on depression-like symptoms and on subsequent MA intake was examined in mice genetically prone to binge-level MA consumption. Binge-level MA intake was induced using a multiple-bottle choice procedure in which mice were offered one water drinking tube and three tubes containing increasing concentrations of MA in water, or four water tubes (control group). In two studies, depression-like symptoms were measured using a tail-suspension test and a subsequent forced-swim test, after forced abstinence of 6 and 30 hours from a 28-day course of chronic MA intake. An additional study measured the same depression-like symptoms, as well as MA intake, after prolonged abstinence of 1 and 2 weeks. MA high drinking mice and one of their progenitor strains DBA/2J escalated their MA intake with increasing MA concentration; however, MA high drinking mice consumed almost twice as much MA as DBA/2J mice. Depression-like symptoms were significantly higher early after MA access was withdrawn, compared to levels in drug-naïve controls, with more robust effects of MA withdrawal observed in MA high drinking than DBA/2J mice. When depression-like symptoms were examined after 1 or 2 weeks of forced abstinence in MA high drinking mice, depression-like symptoms dissipated, and subsequent MA intake was high. The MA high drinking genetic mouse model has strong face validity for human binge MA use and behavioral sequelae associated with abstinence.

AB - Binge methamphetamine (MA) users have higher MA consumption, relapse rates and depression-like symptoms during early periods of withdrawal, compared with non-binge users. The impact of varying durations of MA abstinence on depression-like symptoms and on subsequent MA intake was examined in mice genetically prone to binge-level MA consumption. Binge-level MA intake was induced using a multiple-bottle choice procedure in which mice were offered one water drinking tube and three tubes containing increasing concentrations of MA in water, or four water tubes (control group). In two studies, depression-like symptoms were measured using a tail-suspension test and a subsequent forced-swim test, after forced abstinence of 6 and 30 hours from a 28-day course of chronic MA intake. An additional study measured the same depression-like symptoms, as well as MA intake, after prolonged abstinence of 1 and 2 weeks. MA high drinking mice and one of their progenitor strains DBA/2J escalated their MA intake with increasing MA concentration; however, MA high drinking mice consumed almost twice as much MA as DBA/2J mice. Depression-like symptoms were significantly higher early after MA access was withdrawn, compared to levels in drug-naïve controls, with more robust effects of MA withdrawal observed in MA high drinking than DBA/2J mice. When depression-like symptoms were examined after 1 or 2 weeks of forced abstinence in MA high drinking mice, depression-like symptoms dissipated, and subsequent MA intake was high. The MA high drinking genetic mouse model has strong face validity for human binge MA use and behavioral sequelae associated with abstinence.

KW - 4-bottle choice

KW - addiction

KW - forced abstinence

KW - forced-swim test

KW - selected-lines

KW - tail-suspension test

UR - http://www.scopus.com/inward/record.url?scp=85057440269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057440269&partnerID=8YFLogxK

U2 - 10.1111/gbb.12533

DO - 10.1111/gbb.12533

M3 - Article

JO - Genes, Brain and Behavior

JF - Genes, Brain and Behavior

SN - 1601-1848

M1 - e12533

ER -